Onyx BiotecNSE:ONYX 13 OCF Margin % is 7.75% as of Mar. 2026, which is 238% above its 10-year median of 2.29. GuruFocus rates NSE:ONYX with a GF Score™ of 13/100. The stock has 6 warning signs investors should review. Among 816 Medical Devices & Instruments companies, Onyx Biotec ranks worse than 64.22% on this metric.
The historical rank and industry rank for Onyx Biotec's OCF Margin % or its related term are showing as below:
NSE:ONYX'
s OCF Margin % Range Over the Past 10 Years
Min: -2.15 Med: 2.29 Max: 15.79
Current: -2.15
During the past 5 years, the highest OCF Margin % of Onyx Biotec was 15.79%. The lowest was -2.15%. And the median was 2.29%.
NSE:ONYX's OCF Margin % is ranked worse than 64.22% of 816
companies
in the Medical Devices & Instruments industry
Industry Median: 5.84
vs NSE:ONYX: -2.15
Onyx Biotec OCF Margin % Related Terms
Onyx Biotec OCF Margin % Historical Data
* Premium members only.
The historical data trend for Onyx Biotec's OCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:ONYX vs ISRG, BDX, MDLN: OCF Margin % Comparison
For the Medical Instruments & Supplies subindustry, Onyx Biotec's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Onyx Biotec OCF Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Onyx Biotec's OCF Margin % distribution charts can be found below:
* The bar in red indicates where Onyx Biotec's OCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Onyx Biotec (NSE:ONYX) has a OCF Margin % of 7.75% as of Mar. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Onyx Biotec and its competitors. This is 238% above median its historical median of 2.29. According to the industry distribution chart, Onyx Biotec ranks #524 out of 816 companies in the Medical Devices & Instruments industry, placing it in the top 64.2%.
Is Onyx Biotec's OCF Margin % too high?
Onyx Biotec's current OCF Margin % of 7.75% is 238% above median its 10-year median of 2.29. The Medical Devices & Instruments industry median OCF Margin % is 5.84. Onyx Biotec's value of 7.75% is 32.7% above this industry median. Based on the distribution chart, Onyx Biotec ranks #524 out of 816 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Onyx Biotec has a GF Score™ of 13/100, reflecting its overall financial health beyond just this single metric.
How does Onyx Biotec's OCF Margin % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Onyx Biotec ranks #524 out of 816 companies for OCF Margin %. This places Onyx Biotec in the lower half of its industry. The industry median OCF Margin % is 5.84. Onyx Biotec's value of 7.75% is 32.7% above this benchmark. While the company's 10-year median is 2.29 vs. the industry median of 5.84, Onyx Biotec has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Medical Devices & Instruments company?
The median OCF Margin % among Medical Devices & Instruments companies is 5.84, based on 816 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Onyx Biotec's current OCF Margin % of 7.75% is 32.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Onyx Biotec and its competitors. For the Medical Devices & Instruments industry, the median OCF Margin % is 5.84 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Onyx Biotec's current OCF Margin % is 7.75%, which is 238% above median its own 10-year median of 2.29. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Onyx Biotec stock overvalued right now?
Onyx Biotec (NSE:ONYX) has a current OCF Margin % of 7.75%. The current OCF Margin % is 7.75%, which is 238% above median its 10-year median of 2.29 and 32.7% above the Medical Devices & Instruments industry median of 5.84. Onyx Biotec's overall GF Score™ is 13/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Onyx Biotec (NSE:ONYX), the current OCF Margin % is 7.75% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Onyx Biotec Ltd is engaged in healthcare segment and offering Sterile Pharmaceutical products ,and acts as a pharmaceutical contract manufacturer. It offering products such as Sterile Water for Injections, Dry Powder Injections and Dry Syrup for India and overseas. Key revenue is generated from Sterile Water for Injections .
13GF Score
Get the complete analysis for NSE:ONYX
OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:ONYX has been successfully added to your 